ONCO 3Sixty 2025 by M|O|C Cancer Care Centre Marks a Landmark Gathering of India’s Largest Multidisciplinary Oncology Community
Pune: M|O|C Cancer Care & Research Centre has commenced ONCO 3Sixty 2025, its flagship national oncology conference, being held from December 12–14 at The Westin, Pune.
The three-day conclave is poised to be one of India’s most influential scientific platforms, bringing together leading clinicians, researchers, and innovators from across the nation. Designed to drive high-level dialogue, meaningful collaboration, and the exchange of cutting-edge insights, the event is shaping conversations that will influence the future of cancer care in India.ONCO 3Sixty 2025 is hosting an impressive community of more than 200 national multidisciplinary oncologists, participating in thought-provoking sessions, interactive case discussions and rigorous scientific deliberations. Strengthening global representation, the conference has welcomed eight internationally acclaimed oncology leaders, whose presence is adding depth and global perspective to the scientific proceedings.
Their expertise in precision oncology, targeted therapies, molecular oncology, thoracic oncology, and advanced therapeutic strategies is helping clinicians explore global advancements and understand how these innovations can be effectively adapted for the Indian context.Among the distinguished international faculty are Dr. Alison Zhang from Macquarie University Hospital and Dr. Adam Brufsky from the University of Pittsburgh School of Medicine, both widely recognized for their work in precision oncology. They are joined by Dr. Axel Grothey from the Mayo Clinic, Dr. Daruka Mahadevan from UT Health San Antonio and Dr. Ross Camidge from the University of Colorado Cancer Center, each contributing specialised insights that are significantly enriching the scientific discourse.Speaking at the conference, Dr. Tushar Patil, Senior Oncologist, M|O|C Cancer Care & Research Centre Pune, said, “ONCO 3Sixty continues to be a powerful bridge between global innovation and Indian clinical practice. This year’s edition reinforces our belief that meaningful dialogue, collaboration, and scientific rigor can accelerate better outcomes for patients across the country. We are proud to create a platform that unites some of the brightest minds in oncology and inspires continuous advancement in cancer care.”The conference is covering more than ten major cancer sites, featuring an expansive range of discussions on emerging therapies, evolving treatment paradigms, and real-world clinical applications. A core highlight of ONCO 3Sixty 2025 is its strong emphasis on case-based learning, enabling participants to engage deeply with practical clinical scenarios and multidisciplinary decision-making, an approach that enhances the applicability of the scientific insights being shared.As ONCO 3Sixty 2025 progresses, it is already setting new benchmarks for oncology conferences in India. With its scale, scientific rigor and global participation, the event stands as a testament to M|O|C’s unwavering commitment to advancing cancer care and nurturing a more informed, collaborative, and future-ready oncology community.
Comments are closed.